Ose Labs Limited
Registered name: OSE LABS LIMITED
Part of Oxford Science Enterprises PLC groupOse Labs Limited does not publish its revenue or profit. Its accounts to 31 Dec 2025 show net assets of £0.
Ose Labs Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2025 showed net assets of £0. The company is classified under “activities of venture and development capital companies” and is based in Oxford.
- Status
- Active
- Location
- Oxford
- Age
- 2 yrs · since 2024
- Type
- Private Limited Company
Key figures
Revenue not disclosed
Ose Labs Limited’s accounts for the year to 31 Dec 2025 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.
We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.
- Employees
- —
- Net assets
- £0
Financial history
Balance-sheet figures — an indirect signal, not revenue or profit.
| Year to | 31 Dec 2025 |
|---|---|
| Disclosure | No P&L |
| Profit & loss | |
| Revenue (turnover) | — |
| Profit (best available) | — |
| Employees (average) | — |
| Ratios | |
| Profit margin | — |
| Balance sheet — indirect signals, not revenue | |
| Cash at bank | £0 |
| Net assets | £0 |
| Source | FullAccounts · bulk data Jul 2026 |
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now £0
- Cash at bank
- —
- Now £0
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Oxford Science Enterprises PLCultimate parent75–100%
- Ose Labs Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (17)
- Oxford Science Enterprises Holdings II LimitedRev. £0 · Profit £243m
- Acionna Therapeutics LtdFigures not disclosed
- Alethio Therapeutics LimitedFigures not disclosed
- Animal Dynamics LimitedRev. — · Profit −£195k
- Circadian Therapeutics LimitedFigures not disclosed
- Credo Therapies LtdFigures not disclosed
- Dyna Therapeutics LimitedFigures not disclosed
- Isogenix LimitedFigures not disclosed
- Kodiform Therapeutics LimitedFigures not disclosed
- Matchbio LimitedFigures not disclosed
- Nuanced Bio LtdFigures not disclosed
- Orfonyx Bio LtdFigures not disclosed
- Ose Manager LimitedFigures not disclosed
- Osi Midco LimitedFigures not disclosed
- Oxford Science Enterprises Holdings III LimitedFigures not disclosed
- Oxford Science Enterprises Holdings LimitedFigures not disclosed
- Thelior Bio LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025, from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.